Sabby Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-350
Closed -$5.76M 178
2017
Q4
$5.76M Sell
350
-352
-50% -$34.1K 0.53% 32
2017
Q3
$4.37M Buy
702
+278
+66% +$21.8K 0.29% 43
2017
Q2
$3.38M Buy
424
+136
+47% +$9.83K 0.22% 52
2017
Q1
$2.05M Sell
288
-561
-66% -$32.9K 0.11% 89
2016
Q4
$4.33M Sell
849
-316
-27% -$14.9K 0.25% 60
2016
Q3
$5.37M Sell
1,165
-2,844
-71% -$116K 0.2% 74
2016
Q2
$12.1M Buy
4,009
+3,716
+1,268% +$124K 0.63% 32
2016
Q1
$939K Buy
293
+222
+313% +$7.82K 0.05% 159
2015
Q4
$414K Sell
71
-180
-72% -$8.92K 0.02% 247
2015
Q3
$1.06M Buy
+251
New +$15.5K 0.04% 226

Other funds holding SAGE